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Introduction

57
Mother-to-child transmission of HIV is a unique setting for studying HIV immunity 58 because both the mother and her infant have circulating maternal HIV-specific neutralizing 59 antibodies (nAbs) at the time of HIV exposure and transmission. Antibodies in the mother could (CDRH3) and 9-11 (CDRL3) amino acids ( Figure 2 ). Clonal family analysis revealed that the 39 125 nAbs comprise 21 clonal families that collectively employ 7 VH genes, 5 VK genes, and 7 VL 126 genes ( Figure 2 ). Two nAbs contained indel events: MG505.18 (family 19) had 6 nucleotides 127 deleted from its VH5-51 FR3 region and MG505.72 (family 8) had 3 nucleotides inserted in its 128 VK3-15 CDR1 region. 
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indicates that 50% neutralization was not achieved at the highest nAb concentration tested. All nAbs were initially tested at 20 µg/ml, 3.0 >20 1.2 16.2 >20 >20 >20 >20 >20 >20 >20 >20 MG505.62 16 8.9 11 6.1 >20 0.6 5.5 >20 >20 >20 >20 >20 >20 >50 >50 MG505.37 16 9.2 11 4.6 >20 0.6 1.9 >20 >20 >20 >20 >20 >20 >20 >20 20 no hit + -MG505.1 17 13.7 9 6.2 >20 0.7 2.9 >20 >20 >20 >20 >20 >20 >50 >50 MG505.19 17 11.3 9 4.1 >20 1.1 2.8 >20 >20 >20 >20 >20 >20 >20 >20 no hit MG505.43 17 9.7 9 5.3 >20 4.7 4.9 >20 >20 >20 >20 >20 >20 >20 >20 MG505.47 17 13.4 9 5.6 >20 1.4 2.0 >20 >20 >20 >20 >20 >20 >50 >50 3 no hit + -MG505.59 17 9.1 9 5.6 >20 0.6 2.6 >20 >20 >20 >20 >20 >20 >50 >50 MG505.87 17 9.9 9 4.1 >20 1.5 3.3 >20 >20 >20 >20 >20 >20 >50 >50 MG505.108 17 11.3 9 5.0 >20 2.0 9.6 >20 >20 >20 >20 >20 >20 >20 >20 4
MG505.112 V1-24 D3-22 J4 21 7.0 VK4-1 J5 9 4.4 >20 0.5 5.2 >20 >20 >20 >20 >20 >20 >20 >20 1 no hit + -MG505.3 20 7.1 10 3.0 >20 0.6 1.1 17.6 >20 >20 >20 >20 >20 >20 >20 23 no hit + -MG505.17 20 5.8 10 5.7 >20 0.7 10.2 >20 >20 >20 >20 >20 >20 >50 >50 MG505.55 20 7.6 10 3.3 >20 0.6 6.2 >20 >20 >20 >20 >20 >20 >20 >20 6
MG505.80 V1-24 D1-26 J1 17 11.0 VL6-57 J2 10 8. 
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To map epitope specificities of each clonal nAb family, we used a combination of phage 187 immunoprecipitation sequencing (PhIP-seq) (24) (Figures 1 and 2 ) and enzyme-linked 188 immunosorbent assays (ELISA) ( Figure 2 ). For PhIP-seq, we utilized a previously described 189 phage library (24) that contains multiple HIV Env sequences: consensus sequences for clades 
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MG505.52), we observed weak but significant enrichments of a peptide that truncated the 199 minimal epitope sequence suggesting this is a core part of the epitope ( Figure 3A , blue 200 residues).
201
Since the library included sequences of several different HIV-1 variants, our PhIP-seq 202 data also allowed us to gain some insight into which amino acids were preferred at highly 203 variable residues within the library sequences. Interestingly, while we observed some variation Figure 1 ). Of note, in all three cases these preferentially enriched peptides were the same 211 amino acid residues found in the autologous viruses from both MG505 and BG505 Envs ( Figure   212 3B). In all nine cases, the V3-peptides that bound to the nAbs were identical to the 213 BG505.W6.C2 Env V3 sequence ( Supplementary Figure 1) , which is also identical to the V3 214 regions of six of seven MG505 W0 Env sequences ( Figure 3B and (1)).
215
These V3-targeting families exclusively employed heavy chain genes VH1-69-2, VH5-216 10-1, or VH5-51 ( Figure 2 ). There were significant correlations between RF-ADCC activity and 217 V3 specificity (p < 0.0001) and RF-ADCC activity and Tier 2 Env neutralization (p = 0.0015)
218
( Figure 4 ).
219
The remaining 12 nAb family representatives that were tested by PhIP-seq did not 220 significantly enrich for any phage in the library, suggesting that they may target conformational 221 epitopes that cannot be detected in the 39-mer peptides expressed by phage in the library. To 222 broadly map the epitope specificities of these 12 non-V3-specific nAbs, we employed ELISA 223 assays using gp120 and gp41 antigens. Eleven of twelve families bound gp120 monomer 11 
249
5A). We found that only the V3-specific nAb families neutralized MG505.W0.G2, which was the 250 maternal virus most potently neutralized by the plasma ( Figure 5A ). The nAbs did not neutralize 251 any other autologous MG505 or vertically-transmitted BG505 viruses.
252
The V3 region of MG505.W0.G2 is identical to that of the other maternal and infant 253 viruses, with the exception of MG505.W0.H3 which has a R310H substitution ( Figure 3B ). To 254 explore the possibility that the V3 nAbs bound the majority of the MG505 and BG505 variants, 255 even though they did not neutralize them, we tested them for Env binding via cell-surface 256 binding assays. Indeed, detectable binding was observed for all V3 nAbs to all autologous Envs 257 expressed on the surface of cells ( Figure 5B ). We also tested three gp120 nAbs that were not 258 V3-specific. These also bound to cell surface-expressed Env, albeit at lower levels ( Figure >50  >50  >20  >50  >50  >50  >50  >20  >20  >20  2  MG505.37  >50  >50  >20  >50  >50  >50  >50  >20  >20  >20  3 MG505 290 families 3, 9, and 13 ( Figure 6A ). These nAb families ranked 65 th , 400 th , and 278 th largest within 291 the IgG repertoire, representing 0.24%, 0.08%, and 0.13% of the total repertoire, respectively.
292
We did not sample any additional clonal IgG sequences stemming from the other 18 nAb 293 families, indicating that family members of these nAbs either absent or rare enough that we did 294 not achieve sufficient sampling depth to detect them (Table 1) .
295
Repertoire analysis is more nuanced for antibody light chains because of the vastly 
300
related to all 21 nAb families, with many families using preferred gene rearrangements that 301 appear as large superfamilies (Figure 6B ,C). One example of a superfamily that can be 302 identified unambiguously is the largest family in our kappa analysis, representing 9.85% of the 303 kappa repertoire, which contains members of both nAb families 12 and 13, though we know 304 these are clonally-distinct families based on their paired heavy chains. This effect can also be 305 seen in Figure 6 , where the three nAb families found in the heavy chain data appear as much 306 larger fractions of the repertoire in the light chain panels ( Figure 6B , C) than in the heavy chain 307 panel ( Figure 6A ). 308 309 310 
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The MG505 nAbs were isolated using a high-throughput functional screening method in 338 technical replicate which allowed for less biased discovery of HIV-neutralizing antibodies than 339 Env bait-based approaches, which tend to target antibodies of certain specificities. The diversity 340 of gene usage within the resulting 39 nAbs was striking, especially considering that the screen 341 was not saturating and that there were likely additional families that contributed to the breadth of 342 the MG505 response. Also striking was the fact that we isolated multiple members of 10 clonal 343 families despite their relative rarity in the repertoire, as was indicated by our failure to find 344 additional clonal members of most of these families by deep sequencing. Despite sampling a 345 diverse set of nAbs, including low frequency families, we did not recapitulate the MG505 P31 346 plasma breadth for heterologous HIV-1 neutralization. Thus, additional nAbs, either from 347 undiscovered families or other clones from families already identified here, likely contributed to 348 the MG505 plasma response. It is possible that 1) the bnAb lineages responsible for the breadth 349 are exceedingly rare populations and we missed them, 2) the antibody-secreting cells (ASCs) 350 and memory cells of the presumed bnAb lineages were not localized to the blood, 3) complex 351 germinal center dynamics resulted in functional differences between the circulating blood 352 memory B cells that we sampled and the plasma antibody-contributing ASCs from the same 353 bnAb lineage, or 4) that the functional screening approach we used did not detect some 
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We used a novel phage immunoprecipitation approach to map the epitopes of these 363 antibodies and found that 9 of the 21 families recognized a linear epitope in V3 that includes the 364 GPGQ sequence that is a common target for V3 nAbs (28, 29). These V3-specific nAbs were 365 capable of both Tier 2 heterologous clade A virus neutralization and ADCC. There is some 366 evidence that V3 nAbs play a role in MTCT, although the results are not consistent across 367 studies and cohorts. V3-specificity was associated with protection in the clade B Women and 368 Infant Transmission Study (7, 8), but not in the clade C Breastfeeding and Nutrition study (11).
369
Based on evidence suggesting that V3-targeting antibodies can select virus escape mutants 370 and drive neutralization resistance in the autologous virus reservoir (30), it has been proposed 371 that maternal V3 nAbs could drive selection of neutralization-resistant transmitted viruses in 372 MTCT (6). Here we found that while the V3 nAbs bound to all autologous viruses tested, they 373 only neutralized one out of seven variants, indicating that the autologous virus reservoir was 374 mostly resistant to maternal V3-specific antibodies present near the time of transmission.
375
The most potent ADCC-mediating nAbs were all V3-specific. The ability to mediate 376 ADCC was correlated with both V3 specificity and the ability to neutralize a Tier 2 virus. It is 377 possible that V3 specificity could simply enable Tier 2 breadth and ADCC function, especially 378 since V3 antibodies can exhibit weak breadth for Tier 2 viruses due to the viruses' sampling of 379 the open conformational states that allow for V3 binding (31). Given that ADDC activity has 380 been correlated with infant outcomes (13), these highly potent maternal ADCC nAbs may 381 provide clues to the mechanisms of protection of ADCC antibodies.
382
It was surprising that the V3 nAbs only neutralized one maternal variant, despite all 383 maternal and infant viruses having identical sequences within the V3 minimal epitope. It is 384 possible that V3 defines only part of the epitope for these nAbs and/or that factors other than 385 minimal epitope binding affect pseudovirus neutralization, such as occlusion of V3 in the native 386 trimer (32). Despite the lack of autologous virus neutralization, we could detect binding to the 387 cell surface-expressed forms of Env of these same viruses. We also detected binding to the 388 BG505 infant Env SOSIP trimer but not neutralization of the corresponding virus. The single 389 difference between the BG505 Envs used in the binding versus neutralization studies is that the 390 native-like SOSIP had an additional glycan at site 332, but this site is outside of the minimal V3 391 epitope as defined by PhIP-seq. Overall, these studies support the findings of our previous studies of nAbs from infant BF520, which showed that trimer binding and neutralization are not 393 always linked (33).
394
In the effort to devise an effective HIV-1 vaccine, it is important to understand and target 395 for elicitation protective traits of polyclonal antibody responses that can prevent infection in 
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10% non-fat milk and 0.05% Tween-20). MG505 nAbs and control antibodies (gp120-specific 462 VRC01 (39) and gp41-specific QA255.006 (24)) were applied at 10 µg ml -1 in blocking buffer 463 and incubated at 37°C for 2 hours. Wells were washed and incubated with goat anti-human IgG-464 HRP (Sigma) diluted 1:2500 in blocking buffer for 1 hour at RT. After washing, TMB-ELISA 465 solution (Pierce) was added for 10 minutes at RT and then stopped with equal volume 1N 466 sulfuric acid. Absorption was read at 450 nM and positive binding was assessed based on 467 blank-subtracted duplicate average absorbance values of at least two times that of the negative 468 control. log10(p-value) reproducibility threshold when testing these antibodies in PhIP-Seq was 2.3.
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Thus, we considered a phage-displayed peptide as significantly enriched if its -log10(p-value) 505 was ≥ 2.3 in both technical replicates. A phage-displayed peptide was considered to be part of 506 the antibody's epitope sequence only if it was significantly enriched in both conditions tested (2 507 ng and 20 ng). Fold-enrichment of each phage-displayed peptide was also calculated across all 508 monoclonal antibodies tested.
510
Phage that were incubated without any monoclonal antibody served as a negative control for 511 non-specific binding of phage and were used to identify and eliminate background hits. For each 512 monoclonal antibody tested, enriched and unenriched peptides were aligned using Clustal
513
Omega. The minimal epitope of an antibody was defined as the shortest amino acid sequence 514 present in all of the enriched peptides. Logo plots were generated using WebLogo (PMID 515 15173120). For the "phage library" and "not enriched by nAbs" logo plots, only peptides that 516 spanned the full length of the minimal epitope (at least from S308 through D322) were included.
518
Analysis of RF-ADCC correlation with heterologous neutralization and V3 specificity 519 Unpaired, two-tailed t-tests were performed using GraphPad Prism 8.
521
Cell surface Env binding assays 522 Binding to cell surface-expressed Env was measured using a flow cytometry-based assay (42).
523
293T cells (5 x 10 5 cells) were transfected with indicated 1.33 µg HIV-1 env DNA and 2.66 µg 
533
MG505 monoclonal antibody binding to HIV Env SOSIP trimer was measured using biolayer 534 interferometry on an Octet RED instrument (ForteBio). Antibodies diluted to 8 µg mL -1 in a 535 filtered buffer solution of 1X PBS containing 1% BSA, 0.03% Tween-20, and 0.02% sodium 536 azide were immobilized onto anti-human IgG Fc capture biosensors (AHC). BG505.SOSIP.664 537 T332N was diluted to 1 µM in the same buffer as above and a series of four, two-fold dilutions of 538 Env trimer were tested as analyte in solution at a shake speed of 600 rpm at 30ºC. The kinetics 539 of mAb binding were measured as follows: association was monitored for 10 minutes, 540 dissociation was monitored for 6 minutes, and regeneration was performed in 10mM Glycine
541
HCl (pH 1.5). Binding-affinity constants (KD; on-rate, Kon; off-rate, Kdis) were calculated using 542 ForteBio's Data Analysis Software 7.0. Responses (nanometer shift) were calculated using data 543 that were background-subtracted from reference wells and processed by Savitzky-Golay 544 filtering, prior to fitting using a 1:1 model of binding kinetics. 
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Antibody repertoire sequence analysis and clonal family clustering 571 Sequences were preprocessed using FLASH, cutadapt, and FASTX-toolkit as previously 572 described (25, 43) . Sequences from both technical replicates were combined, deduplicated, and 573 annotated with partis (https://github.com/psathyrella/partis) using default options including per-574 sample germline inference (44) (45) (46) . Sequences with internal stop codons, or with out-of-frame 575 CDR3 regions were removed during this step. We did not exclude singletons in an attempt to 576 retain even very rare or undersampled sequences. Sequencing run statistics are detailed in 577 - 
